Venn signs deal with Open Orphan to focus on rare diseases
Company has issued €1.1m in loan notes to fund specialisation in orphan diseases
Venn shares hit new low as sales slide 15%
Clinical trials group falls to a loss but is optimistic for the future
Income more than doubles at clinical trials group Venn
Investment in synthetic skin project that is being sold widens operating loss
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices